Wei-xin Ren
Xinjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
125I stent plus combination therapy for HCC and portal vein tumor thrombosis: a nationwide target trial emulation.
Journal: International journal of surgery (London, England)
Published: June 03, 2025
A Comparative Analysis of the Efficacy of Parallel Stent Versus Conventional Stent Repair in Addressing Dysfunction in Transjugular Intrahepatic Portosystemic Shunt Treatment.
Journal: American journal of therapeutics
Published: January 10, 2025
Omics-imaging signature-based nomogram to predict the progression-free survival of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization.
Journal: World journal of clinical cases
Published: March 04, 2024
Irradiation stent with 125 I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial.
Journal: International journal of surgery (London, England)
Published: September 05, 2022
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Journal: Signal transduction and targeted therapy
Published: June 14, 2022
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).
Journal: Liver cancer
Published: January 03, 2018
Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: April 19, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026